MentionFox
Home › funding signals › Solve Therapeutics, Inc.
Company · SEC filings

Solve Therapeutics, Inc. funding history

Before you sign with, sell to or invest in Solve Therapeutics, Inc.

MentionFox check on Solve Therapeutics, Inc.: only 2 sources on file so far (checked 17 November 2026). Run a full check before you rely on it. mentionfox.com/c/company/solve-therapeutics-inc

Check Solve Therapeutics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Solve Therapeutics, Inc.?

Solve Therapeutics, Inc. has 2 Form D filings on record, from 2024-12-26 to 2025-11-25. Together its new offerings report $98.60M sold.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Solve Therapeutics, Inc.: Raised $48.21M, Form D filed 2025-11-25
Share on LinkedIn Share on X Download image

Keep reading

More on this company and the records around it.

this company elsewhere on the record

What do you want to do with Solve Therapeutics, Inc.?

Is Solve Therapeutics, Inc. a real, registered company?

Solve Therapeutics, Inc. is a registered filer with the SEC (CIK 1905252) and has filed since 2024-12-26. 2 filings are on record, the latest on 2025-11-25.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Solve Therapeutics, Inc.?

Solve Therapeutics, Inc.'s filings name Alan Colowick, Clayton Knox, David Johnson and 5 more as its officers, directors or promoters.

How much has Solve Therapeutics, Inc. raised?

Its new offerings report $98.60M sold across 2 offerings, as its own filings state.

Run the free check on Solve Therapeutics, Inc. →

Based
BELMONT, CALIFORNIA
Year formed
2021
Industry group
Biotechnology
Filings
2
Raised (new offerings)
$98.60M

Every filing

FiledTypeAmount soldTotal offeringRecords
2025-11-25New offering
first sale 2025-11-14
$48.21M$120.54Mdetails · SEC filing
2024-12-26New offering
first sale 2024-12-13
$50.39M$75.58Mdetails · SEC filing

Want the whole picture on Solve Therapeutics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Solve Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Solve Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Solve Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Follow this company

Tools for this story

Each opens in a new tab, filled in for Solve Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/solve-therapeutics-inc
Last updated 2026-11-17
Primary record: SEC filing 1 · SEC filing 2
How much has Solve Therapeutics, Inc. raised? $98.60M in 2 SEC filings. MentionFox, 2026-11-17. https://mentionfox.com/company/solve-therapeutics-inc